ARTICLE | Company News
NeoStem, Phase III Medical deal
January 30, 2006 8:00 AM UTC
PHSM acquired stem cell bank NeoStem for 5 million PHSM shares. The deal values NeoStem at $37,500 using PHSM's close of $0.075 on Jan. 25, the day before the closing was announced. ...